How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Buy
78
OPGN Quote, Financials, Valuation and Earnings
Last price:
$25.5000
Seasonality move
:
32.23%
Day range:
$20.0100 - $27.6000
52-week range:
$0.0000 - $27.6000
Dividend yield:
0%
P/E ratio:
63.77x
P/S ratio:
28.63x
P/B ratio:
25.28x
Volume:
1.5K
Avg. volume:
6.2K
1-year change:
1940%
Market cap:
$256.8M
Revenue:
$5.2M
EPS (TTM):
$0.40
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
OPGN
OpGen, Inc.
|
-- | -- | -- | -- | -- |
|
LAB
Standard BioTools, Inc.
|
$18.5M | -$0.03 | -54.41% | -72.53% | $1.55 |
|
LNSR
LENSAR, Inc.
|
$20.5M | -$0.09 | 30.98% | -90.51% | $15.00 |
|
LUDG
Ludwig Enterprises, Inc.
|
-- | -- | -- | -- | -- |
|
USAQ
QHSLab, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
OPGN
OpGen, Inc.
|
$25.5000 | -- | $256.8M | 63.77x | $0.00 | 0% | 28.63x |
|
LAB
Standard BioTools, Inc.
|
$1.26 | $1.55 | $484.6M | -- | $0.00 | 0% | 3.71x |
|
LNSR
LENSAR, Inc.
|
$12.08 | $15.00 | $144.3M | -- | $0.00 | 0% | 2.42x |
|
LUDG
Ludwig Enterprises, Inc.
|
$0.0400 | -- | $6.5M | -- | $0.00 | 0% | 67,203.89x |
|
USAQ
QHSLab, Inc.
|
$0.6700 | -- | $7.6M | -- | $0.00 | 0% | 3.37x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
OPGN
OpGen, Inc.
|
16.9% | -36,920.421 | 205167.16% | 5.70x |
|
LAB
Standard BioTools, Inc.
|
6.41% | 0.841 | 5.49% | 1.93x |
|
LNSR
LENSAR, Inc.
|
-31.16% | -1.239 | 1.79% | 0.65x |
|
LUDG
Ludwig Enterprises, Inc.
|
-144.65% | -0.654 | 24.05% | 0.00x |
|
USAQ
QHSLab, Inc.
|
162.97% | -1.888 | 73.75% | 0.17x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
OPGN
OpGen, Inc.
|
-$48.1K | -$702.2K | 70.06% | 89.47% | -5625.96% | -$333.3K |
|
LAB
Standard BioTools, Inc.
|
$9.5M | -$23.5M | -22.34% | -24.44% | -120.02% | -$23.1M |
|
LNSR
LENSAR, Inc.
|
$5.8M | -$7.6M | -684.94% | -1013.45% | -52.95% | -$3.5M |
|
LUDG
Ludwig Enterprises, Inc.
|
-- | -$371.4K | -- | -- | -419868.12% | -$139.1K |
|
USAQ
QHSLab, Inc.
|
$475.6K | $96.3K | -35.74% | -- | 13.05% | $2.6K |
OpGen, Inc. vs. Competitors
-
Which has Higher Returns OPGN or LAB?
Standard BioTools, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of -162.05%. OpGen, Inc.'s return on equity of 89.47% beat Standard BioTools, Inc.'s return on equity of -24.44%.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M LABStandard BioTools, Inc.48.51% -$0.09 $427M -
What do Analysts Say About OPGN or LAB?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 17.65%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.55 which suggests that it could grow by 23.02%. Given that Standard BioTools, Inc. has higher upside potential than OpGen, Inc., analysts believe Standard BioTools, Inc. is more attractive than OpGen, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 LABStandard BioTools, Inc.1 2 0 -
Is OPGN or LAB More Risky?
OpGen, Inc. has a beta of -3,423.037, which suggesting that the stock is 342403.692% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.290, suggesting its more volatile than the S&P 500 by 28.967%.
-
Which is a Better Dividend Stock OPGN or LAB?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or LAB?
OpGen, Inc. quarterly revenues are --, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. OpGen, Inc.'s net income of -$608.7K is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, OpGen, Inc.'s price-to-earnings ratio is 63.77x while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 28.63x versus 3.71x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.28.63x 63.77x -- -$608.7K LABStandard BioTools, Inc.3.71x -- $19.6M -$31.7M
-
Which has Higher Returns OPGN or LNSR?
LENSAR, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of -25.94%. OpGen, Inc.'s return on equity of 89.47% beat LENSAR, Inc.'s return on equity of -1013.45%.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M LNSRLENSAR, Inc.40.56% -$0.31 -$9.2M -
What do Analysts Say About OPGN or LNSR?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 17.65%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 24.17%. Given that LENSAR, Inc. has higher upside potential than OpGen, Inc., analysts believe LENSAR, Inc. is more attractive than OpGen, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 LNSRLENSAR, Inc.0 2 0 -
Is OPGN or LNSR More Risky?
OpGen, Inc. has a beta of -3,423.037, which suggesting that the stock is 342403.692% less volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.687, suggesting its less volatile than the S&P 500 by 31.253%.
-
Which is a Better Dividend Stock OPGN or LNSR?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or LNSR?
OpGen, Inc. quarterly revenues are --, which are smaller than LENSAR, Inc. quarterly revenues of $14.3M. OpGen, Inc.'s net income of -$608.7K is higher than LENSAR, Inc.'s net income of -$3.7M. Notably, OpGen, Inc.'s price-to-earnings ratio is 63.77x while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 28.63x versus 2.42x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.28.63x 63.77x -- -$608.7K LNSRLENSAR, Inc.2.42x -- $14.3M -$3.7M
-
Which has Higher Returns OPGN or LUDG?
Ludwig Enterprises, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of -427991.3%. OpGen, Inc.'s return on equity of 89.47% beat Ludwig Enterprises, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M LUDGLudwig Enterprises, Inc.-- -- -$1.4M -
What do Analysts Say About OPGN or LUDG?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 17.65%. On the other hand Ludwig Enterprises, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that OpGen, Inc. has higher upside potential than Ludwig Enterprises, Inc., analysts believe OpGen, Inc. is more attractive than Ludwig Enterprises, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 LUDGLudwig Enterprises, Inc.0 0 0 -
Is OPGN or LUDG More Risky?
OpGen, Inc. has a beta of -3,423.037, which suggesting that the stock is 342403.692% less volatile than S&P 500. In comparison Ludwig Enterprises, Inc. has a beta of 2.470, suggesting its more volatile than the S&P 500 by 146.979%.
-
Which is a Better Dividend Stock OPGN or LUDG?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ludwig Enterprises, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. Ludwig Enterprises, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or LUDG?
OpGen, Inc. quarterly revenues are --, which are smaller than Ludwig Enterprises, Inc. quarterly revenues of --. OpGen, Inc.'s net income of -$608.7K is lower than Ludwig Enterprises, Inc.'s net income of $31.3K. Notably, OpGen, Inc.'s price-to-earnings ratio is 63.77x while Ludwig Enterprises, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 28.63x versus 67,203.89x for Ludwig Enterprises, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.28.63x 63.77x -- -$608.7K LUDGLudwig Enterprises, Inc.67,203.89x -- -- $31.3K
-
Which has Higher Returns OPGN or USAQ?
QHSLab, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of 4.53%. OpGen, Inc.'s return on equity of 89.47% beat QHSLab, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M USAQQHSLab, Inc.64.52% $0.00 $970.2K -
What do Analysts Say About OPGN or USAQ?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 17.65%. On the other hand QHSLab, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that OpGen, Inc. has higher upside potential than QHSLab, Inc., analysts believe OpGen, Inc. is more attractive than QHSLab, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 USAQQHSLab, Inc.0 0 0 -
Is OPGN or USAQ More Risky?
OpGen, Inc. has a beta of -3,423.037, which suggesting that the stock is 342403.692% less volatile than S&P 500. In comparison QHSLab, Inc. has a beta of 0.510, suggesting its less volatile than the S&P 500 by 48.993%.
-
Which is a Better Dividend Stock OPGN or USAQ?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. QHSLab, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. QHSLab, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or USAQ?
OpGen, Inc. quarterly revenues are --, which are smaller than QHSLab, Inc. quarterly revenues of $737.1K. OpGen, Inc.'s net income of -$608.7K is lower than QHSLab, Inc.'s net income of $33.4K. Notably, OpGen, Inc.'s price-to-earnings ratio is 63.77x while QHSLab, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 28.63x versus 3.37x for QHSLab, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.28.63x 63.77x -- -$608.7K USAQQHSLab, Inc.3.37x -- $737.1K $33.4K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Sell
40
BILL alert for Feb 7
Bill Holdings, Inc. [BILL] is up 37.11% over the past day.
Buy
75
PRLB alert for Feb 7
Proto Labs, Inc. [PRLB] is up 28.33% over the past day.
Sell
30
MSTR alert for Feb 7
Strategy, Inc. [MSTR] is up 26.08% over the past day.
